IDXX · 8-K · 20260804PR090033

Net Income and EPS Performance

IDEXX LABORATORIES INC /DE · 2026-08-04 · Importance 42 · Surprise 22

Second-quarter diluted EPS increased 18% to $4.27 from $3.63, or 15% on a comparable basis to $4.07. Net income attributable to stockholders increased to $338.4 million from $294.0 million. EPS included a $0.14-per-share tax benefit from share-based compensation and a $0.06-per-share benefit from year-over-year currency changes. Six-month diluted EPS increased 17% to $7.74 from $6.59.

Key facts

• Net income attributable to stockholders for Q2 2026: $338,412, compared to $293,989 in Q2 2025. source
• Second quarter diluted EPS: $4.27, an increase of 18% as reported and 15% on a comparable basis. source
• Earnings per share diluted for three months ended June 30, 2026: $4.27; basic EPS: $4.29. source